ESMO Open
- ISSN:
- 2059-7029
0
h-индекс
0
Иқтибослар
16
Асарлар
0.00
2-йиллик ўртача иқтибос
Ишонч сигналлари
1 дан 3 сигнал мавжудМустақил ижобий сигналлар — ягона “предатор/қонуний” ҳукми эмас, балки яқинлашувчи тасвир.
- DOAJМаълумот йўқdoaj.org
- ОАК рўйхатиМаълумот йўқОАК
- Яроқли ISSNМавжудISSN
Бу ахборот ёрлиғи, расмий қарор эмас. Сигнал йўқлиги жазо эмас — масалан, минтақавий журнал DOAJ'да бўлмаслиги мумкин.
Вақт бўйича
Вақт бўйича таҳлил
Иқтибос шарҳи
Йиллар бўйича нашрлар (устун) ва иқтибослар (чизиқ)
- Нашрлар
- Иқтибослар
Нашр тарихи
h-индекс эволюцияси
Йиллар бўйича жамланган h-индекс
Энг кўп иқтибос қилинган асарлар
- PO-291 The disbalance of the basic cytokines of the immune system in patients with ovarian cancer on the background of immunotherapy20180 иқтибос
- 10P Neoadjuvant chemotherapy with bevacizumab for IIb stage cervical cancer: Is it time to rethink standard of care?20230 иқтибос
- 19P Neoadjuvant chemotherapy followed by radical surgery vs chemoradiotherapy in patients with cervical cancer (stage IIB, FIGO 2018)20230 иқтибос
- 39P The possibility of predicting the effectiveness of treatment of soft tissue sarcomas on the basis of the properties of their immunologic microenvironment20240 иқтибос
- 35P Beyond microsatellite testing: Tumor mutational burden, should it be routine in patients with GI cancers?20240 иқтибос
- 95P The study of immune microenvironment subpopulations in soft tissue sarcomas20240 иқтибос
- 111P Oncologic outcomes of the pelvic bone tumors20240 иқтибос
- 153P The preoperative treatment of patients with giant cell tumors of limb bones by denosumab therapy20240 иқтибос
- 68P The effectiveness of treatment of ascites due to recurrence of platinum-refractory ovarian cancer using metronomic chemotherapy20240 иқтибос
- 30P Cemiplimab in treatment of metastatic and recurrent cervical cancer20240 иқтибос